AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
EU - Europa 9.985
NA - Nord America 9.548
AS - Asia 5.648
SA - Sud America 2.372
AF - Africa 213
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
AN - Antartide 1
Totale 27.790
Nazione #
US - Stati Uniti d'America 9.373
RU - Federazione Russa 3.244
SG - Singapore 2.518
BR - Brasile 2.092
IE - Irlanda 1.589
CN - Cina 1.578
SE - Svezia 1.361
IT - Italia 1.138
DE - Germania 831
HK - Hong Kong 676
UA - Ucraina 509
FI - Finlandia 414
VN - Vietnam 321
GB - Regno Unito 254
FR - Francia 179
PL - Polonia 172
IN - India 131
AR - Argentina 106
CA - Canada 83
BE - Belgio 75
EC - Ecuador 59
MX - Messico 57
ZA - Sudafrica 55
AT - Austria 54
BD - Bangladesh 51
IQ - Iraq 47
TR - Turchia 47
CI - Costa d'Avorio 42
ID - Indonesia 42
MA - Marocco 35
CZ - Repubblica Ceca 33
JP - Giappone 33
NL - Olanda 32
UZ - Uzbekistan 32
CO - Colombia 29
VE - Venezuela 29
PK - Pakistan 28
ES - Italia 22
KE - Kenya 21
PY - Paraguay 19
AZ - Azerbaigian 18
CL - Cile 17
KZ - Kazakistan 17
EG - Egitto 16
LT - Lituania 14
TN - Tunisia 14
IR - Iran 13
NP - Nepal 12
DZ - Algeria 10
IL - Israele 10
LB - Libano 10
UY - Uruguay 9
AL - Albania 8
DO - Repubblica Dominicana 8
EU - Europa 8
KG - Kirghizistan 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BG - Bulgaria 6
JO - Giordania 6
PT - Portogallo 6
SA - Arabia Saudita 6
SN - Senegal 6
CR - Costa Rica 5
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
NI - Nicaragua 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
BO - Bolivia 4
CH - Svizzera 4
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KW - Kuwait 2
MU - Mauritius 2
NG - Nigeria 2
QA - Qatar 2
RO - Romania 2
TH - Thailandia 2
A1 - Anonimo 1
AO - Angola 1
Totale 27.768
Città #
Moscow 1.714
Dublin 1.588
Dallas 1.369
Singapore 1.151
Chandler 1.101
Jacksonville 1.060
Ashburn 992
Nyköping 833
Beijing 692
Hong Kong 676
Messina 356
Princeton 297
Medford 273
Los Angeles 265
The Dalles 255
Munich 251
Ann Arbor 243
Cambridge 243
Des Moines 209
Dearborn 172
São Paulo 159
Warsaw 156
Boardman 128
Buffalo 127
New York 126
Ho Chi Minh City 113
Helsinki 90
Jinan 82
Wilmington 79
Shenyang 75
Tianjin 73
Brussels 67
San Mateo 66
Turku 66
Rio de Janeiro 64
Woodbridge 63
Redondo Beach 61
Lancaster 60
Belo Horizonte 57
Rome 56
Hanoi 54
Nanjing 48
Hyderabad 46
Bremen 45
Brooklyn 45
Abidjan 41
Curitiba 38
Frankfurt am Main 38
Pune 38
Hebei 36
Vienna 36
Houston 35
Seattle 35
Council Bluffs 34
Brasília 32
Tokyo 32
Ningbo 31
Porto Alegre 31
Nuremberg 30
Zhengzhou 30
Hangzhou 27
Taizhou 27
Tashkent 27
Caltagirone 26
Haikou 26
Johannesburg 26
London 26
Santa Clara 26
Salvador 25
Campinas 24
Dong Ket 24
Montreal 24
Norwalk 24
Catania 23
Guangzhou 23
San Jose 23
Atlanta 22
Guarulhos 22
Milan 22
Falls Church 21
Guayaquil 21
Toronto 21
Brno 20
Düsseldorf 20
Nairobi 20
Quito 20
Changsha 19
Denver 19
Ribeirão Preto 19
San Francisco 19
Baku 18
Ottawa 18
Palo Del Colle 18
Phoenix 18
Poplar 18
Chicago 17
Nürnberg 17
Orem 17
Osasco 17
Augusta 16
Totale 17.123
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 424
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 319
Severe rhabdomyolysis in a patient with “Heat Stroke” 250
Clinical and pathological features of focal myositis 234
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 197
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 195
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 193
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 193
A Nouvel serum MicroRNA signature to screen ATTR 181
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 180
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 172
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 168
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 167
A cytochemical study of apoptosis in metabolic myopathies 166
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 164
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 162
A life threatening case of β-enolase deficiency 159
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 158
Hippo signaling pathway is altered in Duchenne muscular dystrophy 153
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 150
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 149
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 148
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 148
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 146
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 146
A case of vacuolar myopathy during the course of chronic hepatitis C. 143
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 143
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 141
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 141
Role of inflammation and oxidative stress mediators in gliomas. 140
miRNA regulation of Sirtuin-1 expression in human astrocytoma 140
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 138
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 137
Analysis of lipid profile in lipid storage myopathy 137
ANT1 is reduced in sporadic inclusion body myositis. 136
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 134
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 134
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 133
Effect of exercise on telomere length and telomere proteins expression in mdx mice 133
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 133
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 132
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 130
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 128
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 128
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 127
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 127
Pilot study of flavocoxid in ambulant DMD patients. 125
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 124
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 123
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 122
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 121
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 120
Miopatie metaboliche 120
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 120
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 120
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 118
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 117
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 116
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 116
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 116
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 116
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 115
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 115
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 114
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 114
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 113
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 113
Pilot study of flavocoxid in ambulant DMD patients. 112
Severe rhabdomyolysis in a patient with “Heat Stroke” 112
Pilot study of flavocoxid in ambulant DMD patients. 111
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 110
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 110
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 110
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 109
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 109
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 109
Fatal R631C mutation is also present in the adult form of CPTII deficiency 108
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 108
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 108
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 107
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 107
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 106
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 106
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 106
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 105
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 105
Calpain 3 deficiency in Quail Eater's disease 105
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 105
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 105
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 104
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 104
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 103
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 103
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 103
Modulazione della lunghezza telomerica nei diversi gradi di tumore astrogliale nell'uomo. 102
Detection of αII-Spectrin and Breakdown Products in Humans After Severe Traumatic Brain Injury 101
Differential expression of Hippo signaling pathway in human astroglial tumors 101
Studio dell'espressione genica della metalloproteinasi 3 e degli inibitori TIMP-1 e TIMP-2 nei meningiomi cerebrali 100
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 100
study of flavocoxid in ambulant DMD patients. 99
Totale 13.528
Categoria #
all - tutte 100.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021919 0 0 0 0 0 154 54 178 88 253 115 77
2021/20221.852 14 232 31 72 96 27 139 83 35 237 238 648
2022/20234.511 372 384 232 323 350 429 72 259 1.914 17 107 52
2023/20241.206 90 188 77 93 122 222 39 79 12 92 27 165
2024/20255.948 108 61 114 335 279 184 149 1.322 1.408 357 608 1.023
2025/20269.296 875 1.240 1.422 1.164 1.204 3.391 0 0 0 0 0 0
Totale 28.261